Richard P. Billingham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Richard P. Billingham has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
John T. Isler
Swedish Colon & Rectal Clinic
8 shared publications- Amir Loucas Bastawrous
Swedish Cancer Institute, Seattle, USA
3 shared publications Mark H. Kimmins
3 shared publicationsAlessandro Fichera
2 shared publications- David R. Flum
Department of Surgery, University of Washington, Seattle, Washington
2 shared publications Jeffery M. Nelson
2 shared publications
Latest Publications
- 27 October 2022
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 66 (1) , 13-14
Expert Commentary on Causes and Management of Pruritus Ani
- 27 October 2022
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 66 (1) , 13-14
Expert Commentary on Causes and Management of Pruritus Ani
- 24 February 2015
- Published by Elsevier in The American Journal of Surgery
- Vol. 209 (5) , 913-919
The impact of delaying elective resection of diverticulitis on laparoscopic conversion rate
- 24 February 2015
- Published by Elsevier in The American Journal of Surgery
- Vol. 209 (5) , 913-919
The impact of delaying elective resection of diverticulitis on laparoscopic conversion rate
- 1 August 2012
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 215 (2) , 304
Effect of Conflict of Interest on Publication of Collective Review
- 1 August 2012
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 215 (2) , 304
Effect of Conflict of Interest on Publication of Collective Review
- 20 June 2012
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 27 (12) , 1673-1677
Hemorrhoid management in patients with radiation proctitis
- 20 June 2012
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 27 (12) , 1673-1677
Hemorrhoid management in patients with radiation proctitis
- 1 June 2012
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 214 (6) , 909-918e1
Adoption of Laparoscopy for Elective Colorectal Resection: A Report from the Surgical Care and Outcomes Assessment Program
The purpose of this study was to evaluate the adoption of laparoscopic colon surgery and assess its impact in the community at large. The Surgical Care and Outcomes Assessment Program (SCOAP) is a quality improvement benchmarking initiative in the Northwest using medical record-based data. We evaluated the use of laparoscopy and a composite of adverse events (ie, death or clinical reintervention) for patients undergoing elective colorectal surgery at 48 hospitals from the 4th quarter of 2005 through 4th quarter of 2010. Of the 9,705 patients undergoing elective colorectal operations (mean age 60.6 ± 15.6 years; 55.2% women), 38.0% were performed laparoscopically (17.8% laparoscopic procedures converted to open). The use of laparoscopic procedures increased from 23.3% in 4th quarter of 2005 to 41.6% in 4th quarter of 2010 (trend during study period, p < 0.001). After adjustment (for age, sex, albumin levels, diabetes, body mass index, comorbidity index, cancer diagnosis, year, hospital bed size, and urban vs rural location), the risk of transfusions (odds ratio [OR] = 0.52; 95% CI, 0.39-0.7), wound infections (OR = 0.45; 95% CI, 0.34-0.61), and composite of adverse events (OR = 0.58; 95% CI, 0.43-0.79) were all significantly lower with laparoscopy. Within those hospitals that had been in SCOAP since 2006, hospitals where laparoscopy was most commonly used also had a substantial increase in the volume of all types of colon surgery (202 cases per hospital in 2010 from 112 cases per hospital in 2006, an 80.4% increase) and, in particular, the number of resections for noncancer diagnoses and right-sided pathology. The use of laparoscopic colorectal resection increased in the Northwest. Increased adoption of laparoscopic colectomies was associated with greater use of all types of colorectal surgery.
- 1 June 2012
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 214 (6) , 909-918e1
Adoption of Laparoscopy for Elective Colorectal Resection: A Report from the Surgical Care and Outcomes Assessment Program
The purpose of this study was to evaluate the adoption of laparoscopic colon surgery and assess its impact in the community at large. The Surgical Care and Outcomes Assessment Program (SCOAP) is a quality improvement benchmarking initiative in the Northwest using medical record-based data. We evaluated the use of laparoscopy and a composite of adverse events (ie, death or clinical reintervention) for patients undergoing elective colorectal surgery at 48 hospitals from the 4th quarter of 2005 through 4th quarter of 2010. Of the 9,705 patients undergoing elective colorectal operations (mean age 60.6 ± 15.6 years; 55.2% women), 38.0% were performed laparoscopically (17.8% laparoscopic procedures converted to open). The use of laparoscopic procedures increased from 23.3% in 4th quarter of 2005 to 41.6% in 4th quarter of 2010 (trend during study period, p < 0.001). After adjustment (for age, sex, albumin levels, diabetes, body mass index, comorbidity index, cancer diagnosis, year, hospital bed size, and urban vs rural location), the risk of transfusions (odds ratio [OR] = 0.52; 95% CI, 0.39-0.7), wound infections (OR = 0.45; 95% CI, 0.34-0.61), and composite of adverse events (OR = 0.58; 95% CI, 0.43-0.79) were all significantly lower with laparoscopy. Within those hospitals that had been in SCOAP since 2006, hospitals where laparoscopy was most commonly used also had a substantial increase in the volume of all types of colon surgery (202 cases per hospital in 2010 from 112 cases per hospital in 2006, an 80.4% increase) and, in particular, the number of resections for noncancer diagnoses and right-sided pathology. The use of laparoscopic colorectal resection increased in the Northwest. Increased adoption of laparoscopic colectomies was associated with greater use of all types of colorectal surgery.
- 1 November 2011
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 213 (5) , 596-603e1
Perioperative Pharmacologic Prophylaxis for Venous Thromboembolism in Colorectal Surgery
To determine the effectiveness of pharmacologic prophylaxis in preventing clinically relevant venous thromboembolic (VTE) events and deaths after surgery. The Surgical Care Improvement Project recommends that VTE pharmacologic prophylaxis be given within 24 hours of the operation. The bulk of evidence supporting this recommendation uses radiographic end points. The Surgical Care and Outcomes Assessment Program is a Washington State quality improvement initiative with data linked to hospital admission/discharge and vital status records. We compared the rates of death, clinically relevant VTE, and a composite adverse event (CAE) in the 90 days after elective, colon/rectal resections, based on receipt of pharmacologic prophylaxis (within 24 hours of surgery) at 36 Surgical Care and Outcomes Assessment Program hospitals (2005-2009). Of 4,195 (mean age 61.1 ± 15.6 years; 54.1% women) patients, 56.5% received pharmacologic prophylaxis. Ninety-day death (2.5% vs 1.6%; p = 0.03), VTE (1.8% vs 1.1%; p = 0.04), and CAE (4.2% vs 2.5%; p = .002) were lower in those who received pharmacologic prophylaxis. After adjustment for patient and procedure characteristics, the odds were 36% lower for CAE (odds ratio = 0.64; 95% CI, 0.44-0.93) with pharmacologic prophylaxis. In any given quarter, hospitals where patients more often received pharmacologic prophylaxis (highest tertile of use) had the lowest rates of CAE (2.3% vs 3.6%; p = 0.05) compared with hospitals in the lowest tertile. Using clinical end points, this study demonstrates the effectiveness of VTE pharmacologic prophylaxis in patients having elective colorectal surgery. Hospitals that used pharmacologic prophylaxis more often had the lowest rates of adverse events.
- 1 November 2011
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 213 (5) , 596-603e1
Perioperative Pharmacologic Prophylaxis for Venous Thromboembolism in Colorectal Surgery
To determine the effectiveness of pharmacologic prophylaxis in preventing clinically relevant venous thromboembolic (VTE) events and deaths after surgery. The Surgical Care Improvement Project recommends that VTE pharmacologic prophylaxis be given within 24 hours of the operation. The bulk of evidence supporting this recommendation uses radiographic end points. The Surgical Care and Outcomes Assessment Program is a Washington State quality improvement initiative with data linked to hospital admission/discharge and vital status records. We compared the rates of death, clinically relevant VTE, and a composite adverse event (CAE) in the 90 days after elective, colon/rectal resections, based on receipt of pharmacologic prophylaxis (within 24 hours of surgery) at 36 Surgical Care and Outcomes Assessment Program hospitals (2005-2009). Of 4,195 (mean age 61.1 ± 15.6 years; 54.1% women) patients, 56.5% received pharmacologic prophylaxis. Ninety-day death (2.5% vs 1.6%; p = 0.03), VTE (1.8% vs 1.1%; p = 0.04), and CAE (4.2% vs 2.5%; p = .002) were lower in those who received pharmacologic prophylaxis. After adjustment for patient and procedure characteristics, the odds were 36% lower for CAE (odds ratio = 0.64; 95% CI, 0.44-0.93) with pharmacologic prophylaxis. In any given quarter, hospitals where patients more often received pharmacologic prophylaxis (highest tertile of use) had the lowest rates of CAE (2.3% vs 3.6%; p = 0.05) compared with hospitals in the lowest tertile. Using clinical end points, this study demonstrates the effectiveness of VTE pharmacologic prophylaxis in patients having elective colorectal surgery. Hospitals that used pharmacologic prophylaxis more often had the lowest rates of adverse events.
- 1 July 2010
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 14 (7) , 1090-1098
Prophylaxis and Management of Wound Infections after Elective Colorectal Surgery: A Survey of the American Society of Colon and Rectal Surgeons Membership
- 1 July 2010
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 14 (7) , 1090-1098
Prophylaxis and Management of Wound Infections after Elective Colorectal Surgery: A Survey of the American Society of Colon and Rectal Surgeons Membership
- 1 February 2010
- Published by Elsevier in Surgical Clinics of North America
- Vol. 90 (1) , 125-135
Pruritus Ani: Etiology and Management
- 1 February 2010
- Published by Elsevier in Surgical Clinics of North America
- Vol. 90 (1) , 125-135
Pruritus Ani: Etiology and Management